Variations in content of active ingredients causing drug interactions in grapefruit juice products sold in California
Sompon Wanwimolruk1, Paul V Marquez
1School ofPharmacy, Loma Linda University, Loma Linda, CA, USA. swanwimolruk@llu.edu
Abstract:
The content of the active ingredients of grapefruit juice, naringin, naringenin and bergapten, was determined in 20 different commercial products of grapefruit juice sold in California. These included Minute Maid, Dole, Tropicana, Ocean Spray, Ralps, Albertson, Stater Bros, Vons, Langers, etc. The concentrations of naringin, naringenin and bergapten in grapefruit juice were assayed by specific HPLC methods. Naringin was found to be the most abundant flavonoid in grapefruit juice products, followed by naringenin and bergapten. The content of naringin varied among the products, ranging from 104 mg/l (Tropicana ruby red) to 628 mg/l (Ralphs white frozen concentrate). The mean contents of naringin in ruby red (158 +/- 66 [SD] mg/l) and pink (279 +/- 123 mg/l) grapefruit juice products were significantly lower than white (481 +/- 94 mg/l) (p <0.005) grapefruit juice products. Content of naringenin also varied from brand to brand and ranged from 3.9 mg/l (Vons white frozen concentrate) to 31.2 mg/l (Tree Sweet pink). Bergapten content was very low in grapefruit juice products ranging from 0 (not detectable) to 5.5 mg/l. There were no significant differences in naringenin and bergapten contents among the three types of grapefruit juice products. The information gained from this study would be useful in predicting the likelihood of grapefruit juice-drug interactions.
Related Concept Videos
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Pharmacokinetics: Drug–Drug Interactions
Drug toxicity: Drug–Drug Interaction
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
